secukinumab · Medicine question

How does secukinumab affect the interaction between IL-17A and its receptor?

Name: How does secukinumab affect the interaction between IL-17A and its receptor?
Published: 2026-11-08T14:25:28.726Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Secukinumab selectively binds to and neutralises IL-17A, inhibiting its interaction with the IL-17 receptor expressed on various cell types, including keratinocytes.

Sources for this answer

Cosentyx 150mg and 300mg solution for injection in pre-filled syringe and pre-filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 29Document updated 19 August 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about secukinumab